会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • EMULSIFIED COMPOSITION FOR DILUTION AND CANCER VACCINE COMPOSITION
    • 用于稀释和癌症疫苗组合物的乳化组合物
    • US20090136572A1
    • 2009-05-28
    • US11814270
    • 2006-01-19
    • Koichi SaitoYusuke Okawa
    • Koichi SaitoYusuke Okawa
    • A61K9/14A61K39/00A61K47/00
    • C07K7/08A61K9/0019A61K9/107A61K39/0011A61K47/14A61K2039/55566C07K7/06
    • Provided is an emulsified composition for diluting a cancer antigen peptide or a dimer thereof. Also provided is a novel cancer vaccine composition or specific CTL inducer that efficiently induces CTL irrespective of the type of cancer antigen peptide when mixing the emulsified composition for dilution and a water phase comprising a cancer antigen peptide or a dimer thereof.The present invention relates to an emulsified composition for diluting a cancer antigen peptide or a dimer thereof, comprising a particular ester, a particular surfactant, a particular emulsifier, and a water phase. The present invention also relates to a cancer vaccine composition or specific CTL inducer obtained by freshly diluting and mixing a water phase comprising a cancer antigen peptide or a dimer thereof with the emulsified composition for dilution.
    • 提供了用于稀释癌抗原肽或其二聚体的乳化组合物。 还提供了当混合用于稀释的乳化组合物和包含癌抗原肽或其二聚体的水相时,与癌抗原肽类型无关地有效诱导CTL的新型癌症疫苗组合物或特异性CTL诱导剂。 本发明涉及用于稀释癌抗原肽或其二聚体的乳化组合物,其包含特定的酯,特定的表面活性剂,特定的乳化剂和水相。 本发明还涉及通过将包含癌抗原肽或其二聚体的水相与用于稀释的乳化组合物新鲜稀释和混合而获得的癌症疫苗组合物或特异性CTL诱导剂。
    • 2. 发明授权
    • Emulsified composition for dilution and cancer vaccine composition
    • 用于稀释和癌症疫苗组合物的乳化组合物
    • US08178102B2
    • 2012-05-15
    • US11814270
    • 2006-01-19
    • Koichi SaitoYusuke Okawa
    • Koichi SaitoYusuke Okawa
    • A61K39/39B01F3/08
    • C07K7/08A61K9/0019A61K9/107A61K39/0011A61K47/14A61K2039/55566C07K7/06
    • Provided is an emulsified composition for diluting a cancer antigen peptide or a dimer thereof. Also provided is a novel cancer vaccine composition or specific CTL inducer that efficiently induces CTL irrespective of the type of cancer antigen peptide when mixing the emulsified composition for dilution and a water phase comprising a cancer antigen peptide or a dimer thereof.The present invention relates to an emulsified composition for diluting a cancer antigen peptide or a dimer thereof, comprising a particular ester, a particular surfactant, a particular emulsifier, and a water phase. The present invention also relates to a cancer vaccine composition or specific CTL inducer obtained by freshly diluting and mixing a water phase comprising a cancer antigen peptide or a dimer thereof with the emulsified composition for dilution.
    • 提供了用于稀释癌抗原肽或其二聚体的乳化组合物。 还提供了当混合用于稀释的乳化组合物和包含癌抗原肽或其二聚体的水相时,与癌抗原肽类型无关地有效诱导CTL的新型癌症疫苗组合物或特异性CTL诱导剂。 本发明涉及用于稀释癌抗原肽或其二聚体的乳化组合物,其包含特定的酯,特定的表面活性剂,特定的乳化剂和水相。 本发明还涉及通过将包含癌抗原肽或其二聚体的水相与用于稀释的乳化组合物新鲜稀释和混合而获得的癌症疫苗组合物或特异性CTL诱导剂。